共 50 条
- [2] Characteristics and Clinical Outcomes in Patients With Polycythemia Vera Receiving Ruxolitinib After Hydroxyurea: A Longitudinal Analysis From the Prospective Observational Study of Patients With Polycythemia Vera in US Clinical Practices Trial (REVEAL) CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S404 - S405
- [4] Mortality and Causes of Death of Patients with Polycythemia Vera: Analysis of the REVEAL Prospective, Observational Study CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S355 - S355
- [6] Clinical and Disease Characteristics From REVEAL at Time of Enrollment (Baseline): Prospective Observational Study of Patients With Polycythemia Vera in the United States CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (12): : 788 - +
- [9] Are Patients with High-Risk Polycythemia Vera (PV) Receiving Cytoreductive Medications? A Retrospective Analysis of Real-World Data CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S356 - S356